# Cingulate (CING) — News

CING · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/cing/news

## Recent headlines

- [Cingulate Inc: Ascendant Capital Markets cuts target price to $44 from $52](https://www.ainvest.com/news/cingulate-ascendant-capital-markets-cuts-target-price-44-52-2608) — AInvest Wire, Aug 20, 2026
  Ascendiant Capital has revised its price target for Cingulate Inc. (NASDAQ:CING), lowering it to $44 from a previous $52, while maintaining a "Buy" rating on the stock. The updated target reflects a reassessment of the company’s valuation, balancing the inherent risks of its development-stage…
- [Cingulate: cash & cash equivalents provide runway thru mid-2027](https://www.ainvest.com/news/cingulate-cash-cash-equivalents-provide-runway-mid-2027-2608) — AInvest Wire, Aug 13, 2026
  Cingulate Inc. (NASDAQ: CING) reported a net loss of $9.3 million for the first quarter ended March 31, 2026, compared to a loss of $3.9 million in the same period in 2025. Despite the increased loss, the company’s cash and cash equivalents rose to $25.9 million as of March 31, 2026, up from $10.95…
- [Cingulate to resubmit NDA to FDA as promptly as practicable](https://www.ainvest.com/news/cingulate-resubmit-nda-fda-promptly-practicable-2608) — AInvest Wire, Aug 13, 2026
- [Cingulate has nearly $30 mln in cash reserves to fund operations into 2027](https://www.ainvest.com/news/cingulate-30-mln-cash-reserves-fund-operations-2027-2606) — AInvest Wire, Jun 2, 2026
- [Cingulate receives complete response letter from FDA for CTX-1301](https://www.ainvest.com/news/cingulate-receives-complete-response-letter-fda-ctx-1301-2606) — AInvest Wire, Jun 2, 2026
  Cingulate Inc. (NASDAQ: CING) recently received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for CTx-1301, a once-daily ADHD treatment . The CRL indicates that the application cannot be approved in its current form and outlines…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).